COMBINATION CHEMOTHERAPY OF HEPATOCELLULAR CANCER - COMPARISON OF ADRIAMYCIN+VM-26+5-FLUOROURACIL WITH MAMSA+VM-26+5-FLUOROURACIL

被引：9

作者：

BEZWODA, WR ^{[1
]}

WEAVING, A ^{[1
]}

KEW, M ^{[1
]}

DERMAN, DP ^{[1
]}

机构：

[1] JOHANNESBURG GEN HOSP,JOHANNESBURG,SOUTH AFRICA

来源：

关键词：

D O I：

10.1159/000226478

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：207 / 209

页数：3

共 13 条

[1] BEZWODA WR, 1982, P ASCO, V1, P353
[2] BUKOWSKI RM, 1982, CANCER TREAT REP, V66, P1651
[3] A PHASE-II STUDY OF NEOCARZINOSTATIN (NSC 157365) IN MALIGNANT HEPATOMA - AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT-STUDY
FALKSON, G
VONHOFF, D
KLAASSEN, D
DUPLESSIS, H
VANDERMERWE, CF
VANDERMERWE, AM
CARBONE, PP
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 4 (01) : 33 - 36
[4] FALKSON G, 1984, CANCER, V54, P970, DOI 10.1002/1097-0142(19840915)54:6<970::AID-CNCR2820540604>3.0.CO
[5] 2-7
[6] FALKSON G, 1981, INT C SERIES, V542, P455
[7] GEDDES EW, 1970, CANCER, V25, P1271, DOI 10.1002/1097-0142(197006)25:6<1271::AID-CNCR2820250604>3.0.CO
[8] 2-F
[9] LEWIS BJ, 1984, INT C SERIES, V659, P63
[10] MELIA WM, 1983, CANCER, V51, P206, DOI 10.1002/1097-0142(19830115)51:2<206::AID-CNCR2820510206>3.0.CO